On Aug. 1, 2023, the FDA and the DEA issued a joint statement discussing the ongoing stimulant shortage, highlighting several remediation strategies and potential alternatives as challenges continue to be worked through to help inform your...
On Aug. 1, 2023, the FDA and the DEA issued a joint statement discussing the ongoing stimulant shortage, highlighting several remediation strategies and potential alternatives as challenges continue to be worked through to help inform your...
On Aug. 1, 2023, the FDA and the...